For example, IL-33 has been shown to enhance antigen-induced bronchoconstriction via MC activation (14), and to induce IL-13-dependent airway hyperresponsiveness in vivo, possibly via MC activation and release of IL-13 (15). Here, IL13 is linked to airway hyperresponsiveness.